Predict your next investment

Exacad company logo
INDUSTRIAL | Manufacturing / Rubber & Plastic Product Manufacturing
exacad.com

See what CB Insights has to offer

Founded Year

1995

Stage

Grant | Alive

Total Raised

$1.32M

Last Raised

$1.32M | 1 yr ago

About Exacad

Exacad designs and manufactures multi-material plastic injection molds.

Exacad Headquarter Location

94-B, boulevard des Entreprises

Boisbriand, Quebec, J7G 2T3,

Canada

514-990-1908

Latest Exacad News

Injection mold maker Exacad gets funding for COVID-19 medical relief projects

Jun 25, 2020

Injection mold maker Exacad gets funding for COVID-19 medical relief projects The Quebec-based injection mold designer and manufacturer is one of three Canadian companies receiving a total of $6 million in funding from supercluster Next Generation Manufacturing Canada. Topics June 25, 2020by Canadian Plastics Quebec-based injection mold designer and manufacturer Exacad is one of three Canadian companies receiving a total of $6 million in funding from supercluster Next Generation Manufacturing Canada (NGen). The funds are part of a $50-million investment by NGen, the industry-led organization behind Canada’s Advanced Manufacturing Supercluster, for manufacturers rapidly responding to COVID-19. Exacad, headquartered in Boisbriand, Que., has received $1.8 million covering the total project cost of purchasing new equipment that will help increase production of advanced plastic medical molds to produce the plastic consumables needed for rapid diagnostics related to COVID-19. The two other companies receiving funding are Cloud DX, a developer of health data technology based in Kitchener, Ont., which received $1.75 million, half the $3.5 million project cost to develop Pulsewave 2.0., a solution to remotely monitor COVID-19 patients with non-acute symptoms who have been sent home from the hospital but may require virtual care at home to fully recover; and Toronto-based textile computing company Myant Inc., which received $2.5 million for an almost $5 million project to manufacture and deploy the company’s “Skiin” textile-based wearable health monitoring system. “During an unprecedented and challenging time, Canada’s advanced manufacturing companies have really stepped up to the plate and developed innovative solutions that will save lives and improve healthcare,” NGen CEO Jayson Myers said in a statement. “Every single one of these new manufacturing technologies will not only meet the immediate demands of the COVID-19 pandemic, but also build world-leading capabilities in Canadian manufacturing innovation that will support the future well-being and economic prosperity of Canadians as we move forward.” NGen launched its Rapid Response Funding Program from the Innovation Superclusters Initiative in March. So far, 19 projects amounting to $27 million in funding are being developed.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.